Due to the limitations of the PANC-1 transplantation tumor model designed for the present study, the anti-tumor effect of the Anti-MICB-CAR-NK cell function was the primary focus, without direct investigation of the immune activation status of Anti-MICB-CAR-NK cells in vivo, as well as the analysis of persistence. The gene discussed is MICB; the disease is neoplasm.